美国 · SEC FORM 4
INOVIO PHARMACEUTICALS, INC.
INO · Nasdaq · CIK 0001055726 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
16 同一窗口内观察到的 Form 4 交易行
0 sales · 16 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2020-01-13 · Kim Jong Joseph.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 20,816,392
- 上期报告
- 19,921,776
- 日均成交量
- 2,744,152
- 回补天数
- 7.6
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2020-01-13 | Kim Jong Joseph | 买入 (P) | Common Stock | 22,500 | USD 3.11 | USD 69,975 | SEC 申报 ↗ |
Form 4 申报证据
32 transaction lines in the latest 365-day window; 307 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Sumner Michael John | 期权行权／转换 (M) | Common Stock | 9,450 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-20 | Sumner Michael John | 代扣税 (F) | Common Stock | 2,693 | USD 1.23 | USD 3,312 | SEC 申报 ↗ |
| 2026-05-20 | Shea Jacqueline Elizabeth | 期权行权／转换 (M) | Common Stock | 28,296 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (25 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Sumner Michael John | 期权行权／转换 (M) | Common Stock | 9,450 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-20 | Sumner Michael John | 代扣税 (F) | Common Stock | 2,693 | USD 1.23 | USD 3,312 | SEC 申报 ↗ |
| 2026-05-20 | Shea Jacqueline Elizabeth | 期权行权／转换 (M) | Common Stock | 28,296 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-20 | Shea Jacqueline Elizabeth | 代扣税 (F) | Common Stock | 12,306 | USD 1.23 | USD 15,136 | SEC 申报 ↗ |
| 2026-05-20 | KIES PETER | 期权行权／转换 (M) | Common Stock | 8,700 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-20 | KIES PETER | 代扣税 (F) | Common Stock | 4,688 | USD 1.23 | USD 5,766 | SEC 申报 ↗ |
| 2026-05-20 | Humeau Laurent | 期权行权／转换 (M) | Common Stock | 6,027 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-20 | Humeau Laurent | 代扣税 (F) | Common Stock | 2,163 | USD 1.23 | USD 2,660 | SEC 申报 ↗ |
| 2026-05-15 | Sumner Michael John | 期权行权／转换 (M) | Common Stock | 2,385 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-15 | Sumner Michael John | 代扣税 (F) | Common Stock | 680 | USD 1.30 | USD 884 | SEC 申报 ↗ |
| 2026-05-15 | Shea Jacqueline Elizabeth | 期权行权／转换 (M) | Common Stock | 17,744 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-15 | Shea Jacqueline Elizabeth | 代扣税 (F) | Common Stock | 7,717 | USD 1.30 | USD 10,032 | SEC 申报 ↗ |
| 2026-05-15 | KIES PETER | 期权行权／转换 (M) | Common Stock | 4,771 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-15 | KIES PETER | 代扣税 (F) | Common Stock | 2,571 | USD 1.30 | USD 3,342 | SEC 申报 ↗ |
| 2026-05-15 | Humeau Laurent | 期权行权／转换 (M) | Common Stock | 4,771 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-15 | Humeau Laurent | 代扣税 (F) | Common Stock | 1,712 | USD 1.30 | USD 2,226 | SEC 申报 ↗ |
| 2026-02-26 | Weiner David B. | 期权行权／转换 (M) | Common Stock | 972 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-26 | Sumner Michael John | 期权行权／转换 (M) | Common Stock | 16,560 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-26 | Sumner Michael John | 代扣税 (F) | Common Stock | 3,903 | USD 1.79 | USD 6,986 | SEC 申报 ↗ |
| 2026-02-26 | Shea Jacqueline Elizabeth | 期权行权／转换 (M) | Common Stock | 47,033 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-26 | Shea Jacqueline Elizabeth | 代扣税 (F) | Common Stock | 21,714 | USD 1.79 | USD 38,868 | SEC 申报 ↗ |
| 2026-02-26 | KIES PETER | 期权行权／转换 (M) | Common Stock | 15,644 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-26 | KIES PETER | 代扣税 (F) | Common Stock | 9,259 | USD 1.79 | USD 16,574 | SEC 申报 ↗ |
| 2026-02-26 | Humeau Laurent | 期权行权／转换 (M) | Common Stock | 12,376 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-26 | Humeau Laurent | 代扣税 (F) | Common Stock | 5,098 | USD 1.79 | USD 9,125 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | INO |
| CIK | 0001055726 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 307 transaction lines from 2020-01-03 to 2026-05-20 1 P purchase lines · 53 S sale lines · 253 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.